Risedronate Sodium
 OpenBabel02212023462D

 18 17  0  0  0  0  0  0  0  0999 V2000
    0.4623   -2.1596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2522   -1.7471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2522   -0.9221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4623   -0.5096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1768   -0.9221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1768   -1.7471    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4623    0.3154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2522    0.7279    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.9666    1.1404    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6647    0.0135    0.0000 P   0  0  3  0  0  0  0  0  0  0  0  0
   -1.0772   -0.7010    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3791    0.4260    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0
    0.0498   -0.3990    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1603    1.4424    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5541    1.8549    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5728    2.1569    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8748    1.0299    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4161    0.0000    0.0000 Na  0  3  0  0  0 15  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  6  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  4  7  1  0  0  0  0
  5  6  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
  8 14  1  0  0  0  0
 10 11  2  0  0  0  0
 10 12  1  0  0  0  0
 10 13  1  0  0  0  0
 14 15  2  0  0  0  0
 14 16  1  0  0  0  0
 14 17  1  0  0  0  0
M  CHG  2  12  -1  18   1
M  END
>  <CdId>
596

>  <Mol Weight>
305.0941

>  <Formula>
C7H10NNaO7P2

>  <ID>
T1041

>  <Name>
Risedronate Sodium

>  <Synonyms>
Risedronic Acid Sodium

>  <CAS>
115436-72-1

>  <Approved status>
FDA

>  <Disease>
Endocrine system

>  <Indication>
Corticosteroid-Induced Osteoporosis; Male Osteoporosis; Osteitis Deformans; Osteoporosis; Postmenopausal Osteoporosis

>  <Pathways>
Microbiology&Virology; Others

>  <Target>
HBV inhibitor; Others inhibitor

>  <Receptor>
HAP; FPS

$$$$
